Dalton Venture logo

Dalton Venture

Asia, Shanghai, China, Shanghai

Description

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions.

Investor Profile

Dalton Venture has made 9 investments, with 4 in the past 12 months and 22% as lead.

Stage Focus

  • Series A (56%)
  • Series B (22%)
  • Series C (11%)
  • Seed (11%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Hospital
  • Medical
  • Artificial Intelligence (Ai)
  • Wellness
  • Biotechnology
  • Manufacturing
  • Pharmaceutical
  • Biopharma
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dalton Venture frequently co-invest with?

GreatWall Fund
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
FengHe Group
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Fosun RZ Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Kinzon Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Tendence Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Hongdao Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Ares Management
North America, Illinois, United States, Chicago
Co-Investments: 1
DHVC
North America, California, United States, Palo Alto
Co-Investments: 2
CASI Pharmaceuticals
North America, Maryland, United States, Rockville
Co-Investments: 1

What are some of recent deals done by Dalton Venture?

Yuetong Eye Clinic

Shenzhen, Guangdong, China

Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents.

EyewearHospitalMedical
Series ADec 16, 2024
Xiwei Biotechnology

Suzhou, Jiangsu, China

Xiwei Biotechnology is an ophthalmology implanted medical device developer company.

Health CareHospitalManufacturingMedical
Series ADec 6, 2024
Amount Raised: $13,754,591
MacroLux

Shenzhen, Guangdong, China

MacroLux operates as a medical technology company focusing on endoscopic interventional business.

Health CareManufacturingMedicalMedical Device
Series BOct 23, 2024
Amount Raised: $14,032,527
PharMolix Inc.

Beijing, Beijing, China

PharMolix is an AI & Biotechnology company that aims to revolutionize the biomedical industry with multi-modal AI foundation models.

BiopharmaBiotechnologyMedical
SeedAug 14, 2024
Amount Raised: $14,008,938
Juventas

Chaoyang, Liaoning, China

Juventas is a provider and developer of innovative immune cell therapeutic drugs.

BiotechnologyHealth CarePharmaceutical
Series AJul 9, 2019
Amount Raised: $14,515,473
Wellem

Shanghai, Shanghai, China

Wellem is an operator of pediatric clinic franchise.

Health CareHospitalWellness
Series CApr 20, 2019
Deepwise

Beijing, Beijing, China

Deepwise is an artificial intelligence technology-based clinical imaging services provider.

Artificial Intelligence (AI)Health Care
Series BApr 2, 2018
Amount Raised: $23,884,590
Deepwise

Beijing, Beijing, China

Deepwise is an artificial intelligence technology-based clinical imaging services provider.

Artificial Intelligence (AI)Health Care
Series ANov 13, 2017
Amount Raised: $22,591,722
Wellem

Shanghai, Shanghai, China

Wellem is an operator of pediatric clinic franchise.

Health CareHospitalWellness
Series AJan 1, 2017